Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

3,4-diaminopyridine phosphate

EU orphan designation number: EU/3/02/124   
Active ingredient: 3,4-diaminopyridine phosphate
Indication: Treatment of Lambert-Eaton myasthenic syndrome
Sponsor: BioMarin Europe Ltd
164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Firdapse on 23/12/2009 with the number EU/1/09/601

   Public summary of scientific opinion     EPAR


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2002 Centralised Orphan - Designation EMEA/OD/050/02 (2002)5445 of 18/12/2002
13/04/2006 Centralised Orphan - Transfer of orphan designation EMEA/OD/050/02/T/01 (2006)1641 of 11/04/2006
22/01/2008 Other procedure
08/06/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/050/02/T/02 (2010)3719 of 04/06/2010